Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.04 per share
-
Shares outstanding
-
106,324,269
-
Total 13F shares
-
9,632,100
-
Share change
-
-1,570,146
-
Total reported value
-
$46,949,000
-
Price per share
-
$4.88
-
Number of holders
-
29
-
Value change
-
-$10,777,157
-
Number of buys
-
11
-
Number of sells
-
16
Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value EUR0.04 per share (PRQR) as of Q1 2016
As of 31 Mar 2016,
ProQR Therapeutics N.V. - Ordinary Shares, nominal value EUR0.04 per share (PRQR) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,632,100 shares.
The largest 10 holders included
JENNISON ASSOCIATES LLC, ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, Redmile Group, LLC, Clearbridge Investments, LLC, MILLENNIUM MANAGEMENT LLC, JANUS CAPITAL MANAGEMENT LLC, FRANKLIN RESOURCES INC, FMR LLC, and HIGHLAND CAPITAL MANAGEMENT LP.
This page lists
29
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.